U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205622
Company: MYLAN TECHNOLOGIES
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
RIVASTIGMINE RIVASTIGMINE 4.6MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription AB No No
RIVASTIGMINE RIVASTIGMINE 9.5MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription AB No No
RIVASTIGMINE RIVASTIGMINE 13.3MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/20/2018 ORIG-1 Approval STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/16/2019 SUPPL-1 Labeling-Package Insert, Labeling-Patient Package Insert

Label is not available on this site.

RIVASTIGMINE

FILM, EXTENDED RELEASE;TRANSDERMAL; 4.6MG/24HR
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
EXELON RIVASTIGMINE 4.6MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription Yes AB 022083 NOVARTIS
RIVASTIGMINE RIVASTIGMINE 4.6MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 204403 ALVOGEN
RIVASTIGMINE RIVASTIGMINE 4.6MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 207308 AMNEAL PHARMS
RIVASTIGMINE RIVASTIGMINE 4.6MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 209063 BRECKENRIDGE
RIVASTIGMINE RIVASTIGMINE 4.6MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 205622 MYLAN TECHNOLOGIES
RIVASTIGMINE RIVASTIGMINE 4.6MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 206318 ZYDUS PHARMS

FILM, EXTENDED RELEASE;TRANSDERMAL; 9.5MG/24HR
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
EXELON RIVASTIGMINE 9.5MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription Yes AB 022083 NOVARTIS
RIVASTIGMINE RIVASTIGMINE 9.5MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 204403 ALVOGEN
RIVASTIGMINE RIVASTIGMINE 9.5MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 207308 AMNEAL PHARMS
RIVASTIGMINE RIVASTIGMINE 9.5MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 209063 BRECKENRIDGE
RIVASTIGMINE RIVASTIGMINE 9.5MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 205622 MYLAN TECHNOLOGIES
RIVASTIGMINE RIVASTIGMINE 9.5MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 206318 ZYDUS PHARMS

FILM, EXTENDED RELEASE;TRANSDERMAL; 13.3MG/24HR
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
EXELON RIVASTIGMINE 13.3MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription Yes AB 022083 NOVARTIS
RIVASTIGMINE RIVASTIGMINE 13.3MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 204403 ALVOGEN
RIVASTIGMINE RIVASTIGMINE 13.3MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 207308 AMNEAL PHARMS
RIVASTIGMINE RIVASTIGMINE 13.3MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 209063 BRECKENRIDGE
RIVASTIGMINE RIVASTIGMINE 13.3MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 205622 MYLAN TECHNOLOGIES
RIVASTIGMINE RIVASTIGMINE 13.3MG/24HR FILM, EXTENDED RELEASE;TRANSDERMAL Prescription No AB 206318 ZYDUS PHARMS
Back to Top